Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
Open Access
- 1 July 2013
- journal article
- review article
- Published by Elsevier BV in Immunity
- Vol. 39 (1), 49-60
- https://doi.org/10.1016/j.immuni.2013.07.002
Abstract
No abstract availableThis publication has 112 references indexed in Scilit:
- FLASH assembly of TALENs for high-throughput genome editingNature Biotechnology, 2012
- Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapyCurrent Opinion in Immunology, 2011
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient ColitisMolecular Therapy, 2011
- Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Redirected T Cells in HumansTransplantation and Cellular Therapy, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- A Transposon and Transposase System for Human ApplicationMolecular Therapy, 2010
- Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T CellsMolecular Therapy, 2009
- Expression of IL‐15RA or an IL‐15/IL‐15RA fusion on CD8+ T cells modifies adoptively transferred T‐cell function in cisEuropean Journal of Immunology, 2009
- Engineering higher affinity T cell receptors using a T cell display systemJournal of Immunological Methods, 2008
- Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?Nature Clinical Practice Oncology, 2006